CSTL Q2 2021 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$805M

Q2 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$23M+79.0% YoY

Gross Profit

$19M83.8% margin

Operating Income

-$9M-38.7% margin

Net Income

-$9M-38.6% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

-0.2%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$436M

Total Liabilities

$20M

Stockholders' Equity

$416M

Cash & Equivalents

$368M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$13M	+79.0%
Gross Profit	$19M	$11M	+80.3%
Operating Income	-$9M	-$645,000	-1265.9%
Net Income	-$9M	-$1M	-538.9%